Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 84 tables and 80 figures, this 168-page report "Global Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Region: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire global genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Region.
Based on Virus Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• HSV-1
• HSV-2
Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs
By Route of Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral
• Topical
• Injection
By Patient Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Female
• Male
By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter's Fiver Forces Analysis 38
3 Segmentation of Global Market by Virus Type 42
3.1 Market Overview by Virus Type 42
3.2 HSV-1 44
3.3 HSV-2 45
4 Segmentation of Global Market by Drug Type 46
4.1 Market Overview by Drug Type 46
4.2 Acyclovir 48
4.3 Valacyclovir 49
4.4 Famciclovir 50
4.5 Other Drugs 51
5 Segmentation of Global Market by Route of Administration 53
5.1 Market Overview by Route of Administration 53
5.2 Oral 55
5.3 Topical 56
5.4 Injection 57
6 Segmentation of Global Market by Patient Gender 58
6.1 Market Overview by Patient Gender 58
6.2 Female 60
6.3 Male 61
7 Segmentation of Global Market by Distribution Channel 62
7.1 Market Overview by Distribution Channel 62
7.2 Retail Pharmacies 64
7.3 Hospital Pharmacies 65
7.4 Online Pharmacies 66
7.5 Drug Stores 67
8 Segmentation of Global Market by Region 68
8.1 Geographic Market Overview 2022-2032 68
8.2 North America Market 2022-2032 by Country 72
8.2.1 Overview of North America Market 72
8.2.2 U.S. 76
8.2.3 Canada 81
8.2.4 Mexico 83
8.3 European Market 2022-2032 by Country 85
8.3.1 Overview of European Market 85
8.3.2 Germany 89
8.3.3 U.K. 91
8.3.4 France 93
8.3.5 Spain 95
8.3.6 Italy 97
8.3.7 Netherlands 99
8.3.8 Rest of European Market 101
8.4 Asia-Pacific Market 2022-2032 by Country 103
8.4.1 Overview of Asia-Pacific Market 103
8.4.2 Japan 107
8.4.3 China 110
8.4.4 Australia 112
8.4.5 India 114
8.4.6 South Korea 116
8.4.7 Rest of APAC Region 118
8.5 South America Market 2022-2032 by Country 120
8.5.1 Argentina 123
8.5.2 Brazil 125
8.5.3 Chile 127
8.5.4 Rest of South America Market 129
8.6 MEA Market 2022-2032 by Country 130
8.6.1 UAE 133
8.6.2 Saudi Arabia 135
8.6.3 South Africa 137
8.6.4 Other National Markets 139
9 Competitive Landscape 140
9.1 Overview of Key Vendors 140
9.2 New Product Launch, Partnership, Investment, and M&A 143
9.3 Company Profiles 144
Abbott 144
ADLEY FORMULATIONS 146
Aurobindo Pharma Ltd. 147
Avet Pharmaceuticals Inc. 148
Bausch Health Companies 149
Centurion Remedies 150
Cipla Ltd. 151
Eli Lilly & Company 152
Finecure Pharmaceuticals 153
GlaxoSmithKline Plc 154
Glenmark Pharmaceuticals 155
Macleods Pharmaceuticals 156
Medico Remedies 157
Merck & Co., Inc. 158
Novartis AG 159
Pfizer 160
Reddy's Laboratories 161
Sanofi SA 162
Teva Pharmaceutical Industries Ltd. 163
Torrent Pharma 164
Viatris Inc. 165
Zeelab Pharmacy 166
Zydus Pharmaceuticals, Inc. 167
RELATED REPORTS 168
Executive Summary
Azoth Analytics has released a research report titled "Global Classic Car Insurance Market (2024 Edition)" which provides a complete analysis of the Global Classic Car Insurance industry in terms of market segmentation By Vehicle Type (Vintage, and Classic), By Ownersh...
Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type (Medicines, Surgical Procedures, and Assisted Conception), Channel (Fertility Clinics, Hospitals, Research Institutes, and Others), Services (IVF, Genetic Testing, and Reproductive Tissue Storage and D...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
The Industrial Flue Gas Treatment Systems & Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competiti...
The Automotive Parts Heat Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Heavy Metal Wastewater Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Stainless Steel Surface Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Semiconductor Anodizing Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Swimming Pool Water Treatment Equipment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...